Antibiotic resistant bacteria have become a global concern in clinical and public health aspects due to their ability to resist the effects of antibiotics. Seegene’s multiplex real-time PCR assays detect and identify antibiotic-resistant genes simultaneously.
Drug resistant tuberculosis (DR TB) is concerning among immunocompromised patients, including those with HIV infection. Drug-resistant TB spreads the same way as drug-susceptible TB— through the air from one person to another. Bacteria are put into the air when a person with TB disease of the lungs or throat coughs, sneezes, speaks, or sings, infecting nearby people as they breathe in these bacteria.
Treatment of gonorrhea has become more complex with increasing resistance to fluoroquinolone drugs and the need for monitoring and controlling other options like macrolide or cephalosporin resistance. Drug resistance for M. genitalium—a known contributor to serious health complications—is a similarly concerning emerging problem. Seegene offers multiplex real-time PCR assays that can accurately detect these STIs and drug resistance with a single test.
Drug resistance impacts human healthcare as well as veterinary and agriculture industries. Antibiotic resistant bacteria have become a global concern in clinical and public health aspects due to their ability to resist the effects of antibiotics. Antibiotic resistant bacteria spread from person to person in the community (community-acquisition) or from patient to patient in hospital (hospital acquisition).
H. pylori is the main cause of gastroduodenal diseases and is a common bacterial infection with more than 1.2 million annual new infections in the US alone. Utilizing multiplex real-time PCR-based technology allows for the simultaneous detection of multiple strains of H. pylori increasing sensitivity and reducing turnaround time with fewer lab inefficiencies. This technology can specifically target more drug virulence or antibiotic resistance genes in a single test.